Loading data for MBAI — first visit, this takes a few seconds.
Check-Cap Ltd. (MBAI)
NasdaqCM: MBAI
· Real-Time Price · USD
8.04
+0.02 (0.25%)
At close: Aug 24, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Check-Cap Ltd. (MBAI) Stock Price, Analysis & Data
0.25% (1D)
No data available
| Bid | 5.76 |
| Market Cap | 11.06M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 4.14M |
| 0.82 | |
| 4.62 | |
| 1.74 | |
| n/a | |
| P/B (ttm) | 16.41 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 10.49 |
| Volume | 4,396 |
| Avg. Volume (20D) | 12,299 |
| Open | 8.03 |
| Previous Close | 8.02 |
| Day's Range | 8.03 - 8.21 |
| 52-Week Range | 4.20 - 27.44 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MBAI
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel....
Industry Diagnostics & Research
Sector Healthcare
IPO Date Mar 4, 2015
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol MBAI
Website https://check-cap.com
Financial Performance
In 2025, Check-Cap's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were 4.14M, a decrease of -116.46%.
Financial StatementsEarnings Surprise
Check-Cap has released their quarterly earnings on Nov 27, 2023:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of -3.03 misses estimates by -1.84, with 45.89% YoY growth.
